Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

September 23, 2017

Primary Completion Date

November 18, 2022

Study Completion Date

November 28, 2022

Conditions
Major Depressive DisorderTraumatic Brain Injury
Interventions
BEHAVIORAL

Cognitive Behavioral Therapy for individuals with TBI

Cognitive Behavioral Therapy for depression that has been adapted for a population who has experienced a moderate to severe Traumatic Brain Injury. This is a 12 week long treatment for depression with weekly visits that challenges negative thoughts and behaviors. This version has been specifically developed for the study to account for specific cognitive needs of individuals who have experienced a moderate to severe TBI.

OTHER

Waitlist Control

Participants will be randomized to a waitlist. They will attend biweekly study sessions for 12 weeks to track progress, but will receive their treatment as usual.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Spaulding Rehabilitation Hospital

OTHER

lead

Massachusetts General Hospital

OTHER

NCT03307070 - Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury | Biotech Hunter | Biotech Hunter